UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 194

Sortiert nach

Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment

Pharmacology & therapeutics (Oxford), 2022-08, Vol.236, p.108103-108103, Article 108103

2022

Volltextzugriff (PDF)

Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice

Journal of controlled release, 2019-01, Vol.294, p.165-175

2019

Volltextzugriff (PDF)

Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment

Journal of controlled release, 2018-08, Vol.283, p.223-234

2018

Volltextzugriff (PDF)

Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors

Oncoimmunology, 2018-01, Vol.7 (8), p.e1457596-e1457596

2018

Volltextzugriff (PDF)

Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4

Gene therapy, 2012-10, Vol.19 (10), p.988-998

2012

Volltextzugriff (PDF)

PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice

Gene therapy, 2013-12, Vol.20 (12), p.1124-1130

2013

Volltextzugriff (PDF)

CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging

Gene therapy, 2014-02, Vol.21 (2), p.195-204

2014

Volltextzugriff (PDF)

Oncolytic adenovirus based on serotype 3

Cancer gene therapy, 2011-04, Vol.18 (4), p.288-296

2011

Volltextzugriff (PDF)

Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5 3-Cox2L-D24 in patients with metastatic and refractory solid tumors

Gene therapy, 2010-07, Vol.17 (7), p.892-904

2010

Volltextzugriff (PDF)

In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus responders

International journal of cancer, 2014-06, Vol.134 (12), p.2878-2890

2014

Volltextzugriff (PDF)

Artificially cloaked viral nanovaccine for cancer immunotherapy

Nature communications, 2019-12, Vol.10 (1), p.5747-13, Article 5747

2019

Volltextzugriff (PDF)

1109 POSTER Personalized Cancer Immunotherapy With Oncolytic Adenoviruses Armed With Immunostimulatory Molecules GMCSF or CD40L

European journal of cancer (1990), 2011, Vol.47, p.S127-S127

2011

Volltextzugriff (PDF)

Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors

Nature communications, 2023-11, Vol.14 (1), p.7056-7056, Article 7056

2023

Volltextzugriff (PDF)

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

eLife, 2022-03, Vol.11

2022

Volltextzugriff (PDF)

Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy

Cancers, 2021-07, Vol.13 (14), p.3408

2021

Volltextzugriff (PDF)

Business Continuity Planning: A Comprehensive Approach

Information systems management, 2004-06, Vol.21 (3), p.70-78

2004

Volltextzugriff (PDF)

Characterization of Expanded Gamma Delta T Cells from Atypical X-SCID Patient Reveals Preserved Function and IL2RG-Mediated Signaling

Journal of clinical immunology, 2023-02, Vol.43 (2), p.358-370

2023

Volltextzugriff (PDF)

Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions

Advanced healthcare materials, 2020-09, Vol.9 (17), p.e2000529-n/a

2020

Volltextzugriff (PDF)

Characterization of expanded.d T cells from patient with atypical X-linked severe combined immunodeficiency reveals preserved function and IL2RG-mediated signaling

CLINICAL IMMUNOLOGY, 2023, Vol.250, p.90

2023

Volltextzugriff (PDF)

Homology between cancer and viral epitopes as criteria to design improved cancer vaccines

Annals of oncology, 2017-12, Vol.28, p.xi18-xi18

2017

Volltextzugriff (PDF)

Improving the efficacy of PDL1 blockade by combination with oncolytic vaccines

Annals of oncology, 2016-11, Vol.27, p.viii2-viii2

2016

Volltextzugriff (PDF)

Enhanced anti-cancer vaccines with a new epitope improvement system

Annals of oncology, 2016-11, Vol.27, p.viii2-viii2

2016

Volltextzugriff (PDF)

Development of Patient-Derived 3D Tumor Organoids Combined with Immune Cells, as Preclinical Testing Platform for Personalized Cancer Immunotherapy

MOLECULAR THERAPY, 2023, Vol.31 (4), p.658

2023

Volltextzugriff (PDF)

PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile

Gene therapy, 2005-04, Vol.12 (7), p.579-587

2005

Volltextzugriff (PDF)

1 – 25 von 194

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(175)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(125)
Physical Sciences
(76)
Physics
(61)
Technology
(53)
Chemistry
(40)
Life Sciences & Biomedicine
(36)
Chemistry, Physical
(34)
Humans
(32)
Optics
(31)
Physics, Applied
(31)
Science & Technology - Other Topics
(30)
Materials Science
(27)
Materials Science, Multidisciplinary
(25)
Nanoscience & Nanotechnology
(23)
Medicin Och Hälsovetenskap
(19)
Physics, Condensed Matter
(18)
Animals
(17)
Female
(17)
Male
(17)
Spectroscopy
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment

Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice

Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment

Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors

Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4

PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice

CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging

Oncolytic adenovirus based on serotype 3

Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5 3-Cox2L-D24 in patients with metastatic and refractory solid tumors

In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus responders

Artificially cloaked viral nanovaccine for cancer immunotherapy

1109 POSTER Personalized Cancer Immunotherapy With Oncolytic Adenoviruses Armed With Immunostimulatory Molecules GMCSF or CD40L

Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines

PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification

Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy

Business Continuity Planning: A Comprehensive Approach

Characterization of Expanded Gamma Delta T Cells from Atypical X-SCID Patient Reveals Preserved Function and IL2RG-Mediated Signaling

Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions

Characterization of expanded.d T cells from patient with atypical X-linked severe combined immunodeficiency reveals preserved function and IL2RG-mediated signaling

Homology between cancer and viral epitopes as criteria to design improved cancer vaccines

Improving the efficacy of PDL1 blockade by combination with oncolytic vaccines

Enhanced anti-cancer vaccines with a new epitope improvement system

Development of Patient-Derived 3D Tumor Organoids Combined with Immune Cells, as Preclinical Testing Platform for Personalized Cancer Immunotherapy

PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile

Suchergebnisse filtern